Identification of pro-fibrotic cellular subpopulations in fascia of gluteal muscle contracture using single-cell RNA sequencing
Related Experiment Video
Updated: May 27, 2025

Identification, Isolation, and Characterization of Fibro-Adipogenic Progenitors FAPs and Myogenic Progenitors MPs in Skeletal Muscle in the Rat
Published on: June 9, 2021
Weizhi Zhao1,2,3, Zongchao Li1,2,3, Suzhen Ma1,2,3
1Hengyang Medical School, University of South China, Hengyang, Hunan, 421200, China.
Abstract:
Fibrosis is a common and integral pathological feature in various chronic diseases, capable of affecting any tissue or organ. Fibrosis within deep fascia is implicated in many myofascial disorders, including gluteal muscle contracture (GMC), Dupuytren's disease, plantar fasciitis, iliotibial band syndrome, and chronic muscle pain. Despite its clinical significance, deep fascia fibrosis remains considerably under-researched compared to other fibrotic conditions. Single-cell RNA-sequencing (scRNA-seq) has been used to investigate cellular heterogeneity in fibrotic tissues. However, to our knowledge, only a few studies have applied scRNA-seq to explore cellular heterogeneity in deep fascia, and none have specifically examined fibrotic fascia. In this study, we performed scRNA-seq analysis on fibrotic fascia associated with GMC and compared them to nonfibrotic control fascial samples. Our findings show that fibroblast and macrophage cells play critical roles in pathological tissue remodeling within fibrotic deep fascia. We observed an upregulation of various collagens, proteoglycans, and extracellular matrix (ECM) glycoproteins in contracture deep fascia, attributed to the widespread activation of fibroblast subclusters. Additionally, two pro-fibrotic macrophage subpopulations, SPP1+ MP and ECM-like MP, appear to facilitate ECM deposition in fibrotic deep fascia by either regulating fibroblast activation or directly contributing to ECM production. The SPP1+ MP and ECM-like MP cells, as well as the signal interaction between SPP1+ MP and fibroblast cells, present potential therapeutic target for treating GMC and other related myofascial disorders.
Insights
Deep fascia fibrosis, implicated in myofascial disorders like gluteal muscle contracture, involves activated fibroblasts and pro-fibrotic macrophages. These cells drive extracellular matrix deposition, offering potential therapeutic targets for fibrotic conditions.
Area of Science:
- Connective tissue biology
- Cellular and molecular pathology
- Biomedical research
Background:
- Fibrosis is a pathological hallmark in chronic diseases, affecting diverse tissues.
- Deep fascia fibrosis contributes to myofascial disorders such as gluteal muscle contracture (GMC).
- Research on deep fascia fibrosis, particularly using advanced techniques like single-cell RNA-sequencing (scRNA-seq), is limited.
Purpose of the Study:
- To investigate the cellular heterogeneity of fibrotic deep fascia using scRNA-seq.
- To compare cellular profiles of fibrotic fascia from GMC patients with non-fibrotic controls.
- To identify key cell types and molecular pathways involved in deep fascia fibrosis.
Main Methods:
- Single-cell RNA-sequencing (scRNA-seq) analysis.
- Comparison of fibrotic fascia samples from GMC patients with non-fibrotic fascial tissue.
- Identification and characterization of distinct fibroblast and macrophage subpopulations.
Main Results:
- Fibroblast and macrophage cells are critical in pathological remodeling of fibrotic deep fascia.
- Activated fibroblast subclusters significantly upregulate collagens, proteoglycans, and extracellular matrix (ECM) glycoproteins.
- Two pro-fibrotic macrophage subpopulations (SPP1+ MP and ECM-like MP) were identified, promoting ECM deposition.
Conclusions:
- SPP1+ MP and ECM-like MP macrophages, alongside fibroblast activation, drive ECM deposition in fibrotic deep fascia.
- These specific macrophage subpopulations and their interactions with fibroblasts represent potential therapeutic targets for GMC and related myofascial disorders.

